PMO Interview with the Innovator Series: Volume 2

Peter Hirth, PhD
Video Categories: PMO Interview with the Innovator Series

The publishers of Personalized Medicine in Oncology (PMO) invite you to watch an interview with Peter Hirth, PhD, Chief Executive Officer of Plexxikon. In part one, Dr. Hirth discusses the use of biomarkers, segmenting the population of melanoma patients into subsets, and other aspects of personalized medicine.
September 20, 2013

Personalized Care and the Value Proposition

Linda Bosserman discusses the issues regarding the value of personalized care

January 30, 2014

Communicating Value of Personalized Medicine to All Stakeholders in Healthcare

Listen as Dr Argawala articulates the value proposition of personalized medicine for all stakeholders in healthcare.